comparemela.com

Latest Breaking News On - Zemer gitai - Page 3 : comparemela.com

ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance

ArrePath lands $20M seed financing; names new CEO

ArrePath has raised $20 million in seed financing to advance its proprietary, machine learning-based platform, the Princeton drug research company announced March 3.

Lloyd-payne
Viva-bioinnovator
Fei-shen
Zemer-gitai
Us-centers-for-disease
Princeton-university
Boehringer-ingelheim
Action-fund-scientific
Boehringer-ingelheim-venture-fund
Impact-fund-scientific
Insight-partners

vimarsana © 2020. All Rights Reserved.